id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-3380-0023,FDA,FDA-2018-D-3380,Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group of Oncology Therapeutic Products Guidance for Industry,Other,Guidance,2020-04-14T04:00:00Z,2020,4,2020-04-14T04:00:00Z,,2024-11-06T23:34:46Z,,1,0,09000064844a00bb
FDA-2018-D-3380-0022,FDA,FDA-2018-D-3380,"Developing and Labeling In Vitro Companion Diagnostic Devices for a
Specific Group of Oncology Therapeutic Products; Guidance for
Industry; Availability",Notice,Notice of Availability,2020-04-14T04:00:00Z,2020,4,2020-04-14T04:00:00Z,,2020-04-14T12:44:55Z,2020-07816,0,0,09000064844a23ad
FDA-2018-D-3380-0002,FDA,FDA-2018-D-3380,Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products; Guidance for Industry; Draft Guidance,Other,Guidance,2018-12-07T05:00:00Z,2018,12,2018-12-07T05:00:00Z,2019-02-06T04:59:59Z,2024-11-12T22:50:57Z,,1,0,090000648395ab07
FDA-2018-D-3380-0001,FDA,FDA-2018-D-3380,"Developing and Labeling In vitro Companion Diagnostic Devices for a
Specific Group or Class of Oncology Therapeutic Products; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2018-12-07T05:00:00Z,2018,12,2018-12-07T05:00:00Z,2019-02-06T04:59:59Z,2024-11-12T22:49:40Z,2018-26554,1,0,090000648395867c